Bibliography
- OLSEN J, DIENER HC, HUSSTEDT IW et al.: Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. N Engl. Med. (2004) 350:1104–1110.
- BRANDES JL, SAPER JR, DIAMOND M et al.: Topiramate for migraine prevention: a randomized controlled trial. JAMA (2004) 291: 965–973.
- GOADSBY PJ, LIPTON RB, FERRARI MD: Migraine — current understanding and treatment. N Engl. Med. (2002) 346:257–270.
- STOREY JR, CALDER CS, HART DE, POTTER DL: Topiramate in migraine prevention: a double-blind, placebo-controlled study. Headache (2001) 41:968–975.
- PASCUAL J, SANCHEZ DEL RIO M, MATE OS V et al.: Topiramate for patients with refractory migraine: an observational, multicenter study in Spain. Neurologic (2003) 18:364–367.
- MARTINEZ HR, LONDONO 0, CANTU-MARTINEZ, DEL CARMEN TARIN L, CASTILLO CD: Topiramate as an adjunctive treatment in migraine prophylaxis. Headache (2003) 43:1080–1084.
- SILBERSTEIN SD, NETO W, SCHMITT J, JACOBS D: Topiramate in migraine prevention: results of a large controlled trial. Arch. Neurol (2004) 61:490–495.
- FREITAG FG, COLLINS SD, CARLSON BA et al.: A randomized trial of divalproex sodium extended-release tablets in migraine prophylaxis. Neurology (2002) 58:1652–1659.
- TRONVIK E, STROVNER LJ, HELDE G, SAND T, BOVIM G: Prophylactic treatment of migraine with an angiotensin II receptor blocker: a randomized controlled trial. JAMA (2003) 289:65–69.
- DOGGRELL SA: Migraine and beyond: cardiovascular therapeutic potential for CGRP modulators. Expert Opin. Investig. Drugs (2001) 10:1131–1138.
- DOODS H, HALLERMAYER C, WU D et al.: Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist. Br. Pharmacol (2000) 129:420–423.
- MORENO MJ, ABOUNADER R, HEBERT E, DOODS H, HAMEL E: Efficacy of the non-peptide CGRP receptor antagonist BIBN4096BS in blocking CGRP-induced dilations in human and bovine cerebral arteries: potential implications in acute migraine treatment. Neuropharmacology (2002) 42:568–576.
- THE SUBCUTANEOUS SUMATRIPTAN INTERNATIONAL STUDY GROUP: Treatment of migraine attacks with sumitriptan. N Engl. I Med. (1991) 325:316–321.
- FERRARI MD, ROON KI, LIPTON RB, GOADSBY PJ: Oral triptans (serotonin 5-HTIB/ID agonists) in acute migraine treatment: a meta-analysis of 53 trials. Lancet (2001) 358: 1668-1675.
- TEPPER SJ, MILLSON D: Safety profileof the triptans. Expert Opin. Drug Sal (2003) 2:123–132.